Australia-based Jatcorp will focus on building its nutrition brands and potentially acquire at least one new brand in the upcoming year, as it moves away from product distribution and OEM.
The winners of the NutraIngredients-Asia Awards 2024 have been announced in Bangkok, at a ceremony to celebrate the region’s brightest and best ingredients, products, research and initiatives.
China’s growing liver health supplement category is being driven by consumers seeking products for detoxification, skin brightening, and less so for anti-hangover.
Japan’s beverage giant Kirin has completed the acquisition of FANCL and is now aiming to “become one of the largest health science companies in Asia-Pacific.”
This round-up looks at how Asia-Pacific's health and nutrition companies have fared in their latest financial performance, featuring insights from Comvita, Bubs Australia, Feihe, EZZ Life Sciences, and H&H Group.
China energy drink heavyweight EastRoc is moving to a multi-beverage portfolio, hoping to establish itself as a leader in the wider beverage industry and not just the energy category.
China’s demand for coenzyme Q10 remains high but gross margin from the business is at the lower end, says Kingdomway, also the owner of health supplement brand Doctor’s Best.
Here is a round-up on the latest nutraceutical trends, including the rise of femcare products in Japan, how anti-ageing is driving nicotinamide mononucleotide (NMN) use in Hong Kong, and growing demand for red ginseng in China and Vietnam.
Manuka honey maker Comvita says annual revenue for FY24 is down by 12.7 per cent, citing economic slowdown in its largest market, China, as the main reason for the “disappointing” performance.
Bubs Australia, known for its goat milk formula, says its annual revenue has returned to growth on the back of efforts to diversify its business outside of China.
Formula giant Feihe’s half-year profit for FY24 is up 18.1 per cent on the back of increased marketing activities which is said to have acquired over 1.4 million new customers.
Australian firm EZZ Life Science Holdings Limited says net profit for FY24 is up 91 per cent, led by strong e-commerce demand for two of its products in China – nicotinamide mononucleotide (NMN) and a bone health supplement.
Health and Happiness Group (H&H Group) saw its net profit plummeted 49.7 per cent for the first six months of this year – a “challenging period” which it said was primarily due to a downturn and discounting in the infant milk formulas segment.
Qatari dairy firm Baladna has announced plans to double down on its new product innovation and international market expansion strategy, particularly in Algeria, after seeing a record growth in net profits over the first six months of 2024.
Life-Space’s former CEO and founder Craig Silbery is making a return to the human biotics space as he seeks to make Australia a world-class site for manufacturing probiotics and postbiotics, he told our Nutrachampion podcast.
The recent ban on nicotinamide mononucleotide (NMN) into China via cross-border e-commerce was due to safety considerations, says a local industry association, which added that several China companies have put forth their products for health foods registration.
Nicotinamide mononucleotide (NMN) has become one of the hottest health supplement categories in Hong Kong, on the back of strong demand for anti-ageing products, say Catalo, NUNMN, and Homart in this edition of our in-depth VitamINSIGHTS analysis.
South Korea’s domestic demand for red ginseng has slowed down in the past year, but the sector is seeing opportunities overseas, especially in neighbouring East Asian countries and Vietnam.
Japanese adults in their 20s and 30s are most interested in personalised nutrition as compared to the other age groups, a survey conducted by Suntory-backed start-up Rem3dy Health has found.
China Nutrition and Health Food Association (CNHFA) has drafted a set of industry standards to measure nicotinamide mononucleotide (NMN) amounts in health supplements.
Powerade grew an impressive 12% in Australia over the last year. As a result, Coca-Cola Europacific Partners is ramping up production capabilities for the sports drink with its largest ever investment in Australian manufacturing.
Thai-based natural energy drink brand En-Theories has highlighted the paradox between a rising demand for better-for-you beverage options and consumer aversion towards the term ‘energy drinks’ as a major challenge for healthier, more natural alternatives...
China dietary supplement giant BYHEALTH's revenue in the first half of 2024 fell nearly 18 per cent, which it said was mainly due to the changing consumption landscape and stiff market competition.
High temperatures pose micronutrient deficiency risks at the historic 2024 Olympics—the first games with an equal gender split—according to a nutrition advisor working with athletes as they enter the fourth and final week in Paris.
Calcium absorption benefits are resonating strongly with China consumers and this has been a key revenue driver for Haleon’s bone health supplement business in the first half of 2024.
There is rising interest in yeast proteins as food and supplement companies look for novel alternatives to soy and pea protein, with companies such as Japan’s iSDG, South Korea’s Orion Corporation, and America’s Swanson making new launches.
Danone is doubling down on its specialised nutrition offerings, including infant formula and Foods for Special Medical Purposes (FSMP) for China, a market which it said has delivered “stellar performance” for the first half of 2024.
Abbott India says it aims to transform its multi-specialty range, including vitamin D and micronutrient supplements designed for thyroid patients into “big brands” by strengthening its product pipeline.
Thai natural energy drink brand Hippo Energy Drink has revealed that sugar reduction in beverages is not a major priority for most consumers in the Cambodia, Laos, Myanmar and Vietnam (CLMV) markets despite an ongoing trend for this in the rest of the...
Here is a round-up on the latest nutraceutical trends, including how mental wellbeing is set to become one of the key trends in driving the kids supplement industry, as well as how companies are riding on market opportunities brought by the flurry of...
Singapore nutraceutical start-up NanoSG is honing up its AI avatar and online tools, as consumers are relying more on data and information to guide their purchase decision.
Kobayashi Pharmaceutical is appointing a new CEO, while the outgoing chief will return half of his six months remuneration in the aftermath of the firm’s red yeast rice scandal.
Mead Johnson Nutrition parent Reckitt Benckiser saw its shares slip to their lowest level in a decade after news of a bruising Abbott Laboratories verdict rolled in.
Singapore firm Advagen is expanding into China with the upcoming launch of a postbiotic supplement – a white space in which the company is seeing growth opportunities.
China’s Mengniu Dairy is conducting more human clinical studies on Lacticaseibacillus paracasei PC-01 – its proprietary probiotic strain used in its Yoyi C yogurt range.
See new developments from health and nutrition brands across Asia-Pacific, including how Amway is focusing more on longevity and gut health solutions, NYO3’s krill oil innovation strategy for China, reishi specialist GanoHerb’s expansion plans and more.
Amway is paying more attention to longevity, health span, and gut microbiome as it expands the range of products and solutions for its flagship brand Nutrilite.
J.P. Morgan Research predicts that there will be 30 million GLP-1 users in the U.S. by 2030—about 9% of the population. The dietary supplement industry is actively responding to the opportunities presented by the GLP-1 era, with a focus on innovation,...
South Korea’s OEM manufacturer Kolmar BNH is wooing the China market with herbal formulations, as it believes that the concept of 'foods as medicines' is seeing a revival in the country.
The rapid rise of social commerce has brought along a host of problems related to the advertising of dietary supplements and functional foods in Vietnam, according to statistics from the industry association.
Japanese tea company ITO EN is gearing up to set foot into the Indian market for the first time with its flagship ready-to-drink green tea brand Oi Ocha.
